Frequent Links
Hexoprenaline
200px | |
Systematic (IUPAC) name | |
---|---|
(±)-4,4'-{hexane-1,6-diylbis[imino(1-hydroxyethane-2,1-diyl)]}dibenzene-1,2-diol | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
3215-70-1 7px | |
R03AC06 R03CC05 | |
PubChem | CID 3609 |
DrugBank | DB08957 7px |
ChemSpider | 3483 7px |
UNII | G9L6B3W684 7px |
Synonyms | 4-[2-[6-([2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino)hexylamino]-1-hydroxyethyl]benzene-1,2-diol |
Chemical data | |
Formula | C22H32N2O6 |
420.499 g/mol | |
| |
14px (what is this?) (verify) |
Hexoprenaline (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.[1]
Hexoprenaline is also used as a tocolytic agent (i.e., It can suppress labor). Contraindications to its use as a tocolytic agent are cardiovascular disease, surgical shock, tachycardia, diabetes mellitus.
References
- ^ Pinder, RM; Brogden, RN; Speight, TM; Avery, GS (1977). "Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma". Drugs 14 (1): 1–28. PMID 195789. doi:10.2165/00003495-197714010-00001.
|
Lua error in package.lua at line 80: module 'Module:Buffer' not found.